PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by Total Mesorectal Excision (TME) for treatment of locally advanced rectal cancer (LARC). (Alliance N1048)
- Citation:
- JCO vol 41 (suppl 17) LBA2
- Meeting Instance:
- ASCO 2023
- Year:
- 2023
- Type:
- Abstract
- Sub type:
- Plenary
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 4015
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180863 (CCTG); U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG)
- Corr. Author:
- Authors:
- Deborah Schrag Qian Shi Martin Weiser Marc Gollub Leonard Saltz George Chang Rebecca Auer Jeffrey Farma Thom George Hagen Kennecke Benjamin Musher Joel Goldberg Tareq Al baghdadi AmyLou Dueck Ethan Basch Alan Venook Karyn Goodman Eileen O'Reilly Jeffrey Meyerhardt Harvey Mamon
- Networks:
- CA136, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NY016, LAPS-TX035, MCRC, NY021, PA086, PCRC
- Study
- NCCTG-N1048
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2/3
- Keywords: